Evidence-Based Complementary and Alternative Medicine

Traditional Chinese Medicine in Ischemia-Reperfusion Injury 2022


Publishing date
01 Dec 2022
Status
Closed
Submission deadline
12 Aug 2022

Lead Editor

1Southern University of Science and Technology, Shenzhen, China

2University of Southern California, Los Angeles, USA

3Emory University School of Medicine, Atlanta, USA

This issue is now closed for submissions.

Traditional Chinese Medicine in Ischemia-Reperfusion Injury 2022

This issue is now closed for submissions.

Description

Clinically, reperfusion in ischemic tissue usually leads to morbidity and mortality in a wide range of pathological and surgical processes, including myocardial infarction, ischemic stroke, acute kidney injury, trauma, organ transplantation, and cardiothoracic, vascular, and general surgery.

Mechanistically, ischemia-reperfusion injury is associated with an enhanced production of inflammatory mediators, emigration of leukocytes in postcapillary venules, vascular protein leakage, activation of innate and adaptive immune responses, and cell death programs. Unfortunately, current medical strategies do not thoroughly diagnose and prevent this disease. Traditional Chinese medicine (TCM) contains numerous bioactive ingredients, some of which show activity against inflammatory mediators, inappropriate immune responses, and cell death.

This Special Issue invites research clinicians and scientists to submit original articles as well as reviews providing a comprehensive overview and high-quality research of TCM in ischemia-reperfusion injury. The work can evaluate the efficacy and safety of TCM for any kind of ischemia-reperfusion injury. We are particularly interested in manuscripts that report the physiological effects as well as the underlying mechanisms of TCM for ischemia-reperfusion injury.

Potential topics include but are not limited to the following:

  • Systematic review and/or meta-analysis of the use of TCM for ischemia-reperfusion injury
  • Biological and pharmacological activity of TCM for ischemia-reperfusion injury prevention and therapy
  • In vitro and in vivo study and toxicity evaluation of TCM for ischemia-reperfusion injury prevention and therapy
  • Active component screening of traditional medicine in ischemia-reperfusion injury prevention and therapy
  • Characterization of active ingredients in herbal plants that have prevention and therapy properties for ischemia-reperfusion injury
  • Quality control of effective Chinese herbs for ischemia-reperfusion injury prevention and therapy
  • Clinical trials on TCM for pain management ischemia-reperfusion injury prevention and therapy
  • Integrative applications of traditional medicine and modern medicine in ischemia-reperfusion injury prevention and therapy
  • Omics of traditional medicine in ischemia-reperfusion injury prevention and therapy
  • Challenges in the use of traditional medicine in ischemia-reperfusion injury prevention and therapy

Articles

  • Special Issue
  • - Volume 2023
  • - Article ID 9840103
  • - Retraction

Retracted: Network Pharmacology and Molecular Docking Analysis on Molecular Targets and Mechanisms of “Chuanxiong Rhizoma: Radix Salviae miltiorrhizae” Herb Couples in the Treatment of Preeclampsia

Evidence-Based Complementary and Alternative Medicine
  • Special Issue
  • - Volume 2023
  • - Article ID 9853964
  • - Retraction

Retracted: Identification of Diagnostic Biomarkers of Rape Pollen Allergy Based on MRNA Sequencing

Evidence-Based Complementary and Alternative Medicine
  • Special Issue
  • - Volume 2022
  • - Article ID 5263021
  • - Research Article

[Retracted] Prevention of Dexmedetomidine on Postoperative Delirium and Early Postoperative Cognitive Dysfunction in Elderly Patients Undergoing Thoracoscopic Lobectomy

Jing Zhao | Wei-Bo Wang | ... | Yan-An Jiang
  • Special Issue
  • - Volume 2022
  • - Article ID 4040033
  • - Research Article

[Retracted] Influence of the Clinical Nursing Pathway on Nursing Outcomes and Complications of Cervical Carcinoma Patients Undergoing Chemotherapy via PICC

Hongxia Tang | Li Gao | Yahui Li
  • Special Issue
  • - Volume 2022
  • - Article ID 4425680
  • - Research Article

[Retracted] Application of Nursing Outcome-Oriented Integrated Zero-Defect Nursing Combined with Respiratory Function Training in Long-Term Bedridden Patients Undergoing Stroke

Shaona Xu | Yanan Yu | ... | Ying Liu
  • Special Issue
  • - Volume 2022
  • - Article ID 7897027
  • - Research Article

[Retracted] Application of Quantitative Assessment Strategy-Based Nursing Combined with Empathic Nursing in Patients Undergoing Tension-Free Inguinal Herniorrhaphy

Yamei Xiang | Lingyun Xi
  • Special Issue
  • - Volume 2022
  • - Article ID 6153577
  • - Research Article

[Retracted] Identification of Diagnostic Biomarkers of Rape Pollen Allergy Based on MRNA Sequencing

Jianhua Li | Fang Wang | ... | Xia Chen
  • Special Issue
  • - Volume 2022
  • - Article ID 9800993
  • - Research Article

[Retracted] Relationship between Severity of Disease and Postoperative Neurological Recovery in Patients with Cervical Spondylotic Myelopathy Combined with Developmental Spinal Stenosis

Shuai Wang | Jingtao Zhang | ... | Yong Shen
  • Special Issue
  • - Volume 2022
  • - Article ID 5556067
  • - Research Article

Dl-3-n-Butylphthalide (NBP) Mitigates Muscular Injury Induced by Limb Ischemia/Reperfusion in Mice through the HMGB1/TLR4/NF-κB Pathway

Huanhuan Sun | Jueqiong Wang | ... | Xiang Gao
  • Special Issue
  • - Volume 2022
  • - Article ID 5983959
  • - Research Article

[Retracted] Metformin Synergizes with PD-L1 Monoclonal Antibody Enhancing Tumor Immune Response in Treating Non-Small Cell Lung Cancer and Its Molecular Mechanism Investigation

Yifan Wang | Jingguo Hu | ... | Haitao Ma
Evidence-Based Complementary and Alternative Medicine
 Journal metrics
See full report
Acceptance rate7%
Submission to final decision145 days
Acceptance to publication29 days
CiteScore3.500
Journal Citation Indicator-
Impact Factor-
 Submit Check your manuscript for errors before submitting

Article of the Year Award: Impactful research contributions of 2022, as selected by our Chief Editors. Discover the winning articles.